(Q80929410)
Statements
Eight-year immunogenicity and safety of interferon beta-1a-Avonex treatment in patients with multiple sclerosis (English)
Robert M Herndon
Richard A Rudick
Frederick E Munschauer
Michele K Mass
Andres M Salazar
Michael E Coats
Robert Labutta
John R Richert
Stanley L Cohan
Claude Genain
Donald Goodkin
Martin Toal
Katherine Riester